A single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to ...

Baloxavir marboxil, a flu drug seen by Roche as a successor to Tamiflu, significantly sped time to relief for patients highly vulnerable to serious complications.

For further information on how we select topics for development, please see our page about topic selection ...

Xofluza (baloxavir marboxil) is already approved to treat people infected with flu, but the new results make a case to extend its use to include healthy people at risk of contracting the virus ...